NONadezhda Valerievna Orlova

Nadezhda Valerievna Orlova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nadezhda Valerievna Orlova has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    New Approaches to Cell Therapy for Surgical Pathology

    by Y. G. Ivanova, A. N. Muraviov, T. I. Vinogradova, N. V. Orlova, A. A. Gorelova, A. I. Gorbunov, N. M. Yudintceva, Yu. A. Nashchekina, P. K. Yablonskiy, Я. Г. Иванова, et al.

    Mesenchymal stem cells (MSCs) and their derived extracellular vesicles (EVs) are of particular interest in the field of regenerative medicine. This review compares different approaches to the application of MSCs, MSC-EVs in various experimental models, with particular emphasis on their biodistribution. Local administration of the cell-based product appears to be more effective; therefore, the development of new implantation strategies for the topical application of MSCs and EVs remains an important area of research. Hydrogels represent unique biomaterials that have been extensively investigated as delivery systems for drugs, a wide range of biomolecules, and cells. This review evaluates preclinical studies investigating the use of MSCs and MSC-EVs in hydrogels, as well as the safety and feasibility of this strategy. In addition, the major polymers used for hydrogel fabrication are reviewed and analyzed.

  • Open Access

    Prospects for the administration of extracellular vesicles derived from mesenchymal stem cells in regenerative urology.

    by Saint‐Petersburg State Research Institute of Phthisiopulmonology of the Ministry of Healthcare of the Russian Federation, Ya.G. Ivanova, Russia Saint-Petersburg, A.N. Muraviov, T.I. Vinogradova, N.V. Orlova, A.N. Remezova, A.A. Gorelova, A.I. Gorbunov, V.V. Shumko, et al.

    Introduction. In recent decades, mesenchymal stem cells (MSCs) and extracellular vesicles (MSC-EVs) isolated from them have become of particular interest in the field of regenerative medicine. The latter mediate the paracrine action of MSCs, causing anti-inflammatory, proangiogenic, immunomodulatory, antifibrotic effects in damaged tissues/structures/organs. The aim. To study experimental preclinical studies on the use of MSC-EVs in urology. Materials and methods. When searching the medical databases Pubmed, Scolar for the use of MSC-EVs in kidney damage, 8 preclinical studies were found, 2 preclinical studies were found on the stricture model, 3 publications were found on the stress urinary incontinence model, 2 publications were found for damage to the bladder mucosa of various etiologies. Results. The effect of MSC-EVs, comparable to MSCs themselves, is well reflected in a wide array of preclinical studies devoted to the study of the use of MSCEVs in models of various diseases. The use of MSC-EVs seems very promising, including in connection with the possibility of overcoming such problems of cell therapy as immunogenicity and oncogenicity. The described therapeutic potential of MSC-EVs attracts attention in the field of regenerative urology, where their effect was considered in models of kidney damage, strictures of the urethra, ureter, stress urinary incontinence, radiation cystitis. Conclusions. In connection with the obtained results, the relevance of further study of the therapeutic possibilities of MSC-EVs in regenerative urology is beyond doubt. The issues of dosage and the most effective route and method of MSC-EVs administration remain to be further studied.

  • Open Access

    Neurogenic dysfunction of the lower urinary tract in infectious and inflammatory diseases of the spine: is there a correlation with clinical and radiological variants of myelopathy? Preliminary result of the analysis of a single-center cohort

    by Aleksandr Igorevich Gorbunov, Mikhail Aleksandrovich Mushkin, Diana Airatovna Kaumova, Alexandr Nikolaevich Muraviev, Nadezhda Valerievna Orlova, Anna Andreevna Gorelova

    Objective.To study the relationship between clinical and radiation variants of myelopathy and types of the neurogenic dysfunction of the lower urinary tract in patients with infectious spondylitis.Material and Methods.A single-center cohort observational study was conducted with the analysis of medical records and a prospective examination of 20 patients with infectious spondylitis complicated by neurogenic dysfunction of the lower urinary tract.Results.Infectious spondylitis can be complicated by the development of various urodynamic disorders, including neurogenic detrusor hyperactivity (30 %), its combination with detrusor-sphincter dissinergia (30 %) and a decrease in detrusor contractility (40 %). In 50 % of patients, an urodynamic examination revealed an increase in detrusor pressure of more than 40 cm water. There was no connection between the development of any type of lower urinary tract dysfunction and MRI types of myelopathy according to Vendatam, as well as between the level of spinal cord compression and the severity of neurological disorders according to AIS.Conclusion.The results of the study do not confirm the existence of a relationship between the various characteristics of myelopathy in infectious spondylitis and the results of urodynamic examination. The limitation of the reliability of the results is the small number of observations. Studies with a larger sample are required to assess the relationship between the clinical and radiation characteristics of myelopathy and variants of neurogenic dysfunction of the lower urinary tract in patients with infectious spondylitis.

  • Possibilities of application of allogenic tissue engineering products in the experimental urinary bladder reconstruction

    by Nadezhda Valeryevna Orlova, Alexandr Nikolaevich Muraviov, Anna Andreevna Gorelova, Anna Nikolaevna Remezova, Tatiana Ivanovna Vinogradova, Natalia Mikhailovna Yudintceva, Yulia Alexandrovna Nashchekina, Piotr Kazimirovich Yablonsky

    В статье представлены результаты экспериментального применения тканеинженерных конструкций на основе поли-L,L-лактида, содержащих в своем составе аллогенные клетки различного тканевого происхождения. Цель. Экспериментально показать возможность применения аллогенного тканеинженерного трансплантата для замещения дефекта стенки мочевого пузыря (МП). Материал и методы. Исследование выполнено на кроликах-самцах породы шиншилла (n=15), которым после резекции МП выполнялась аугментационная цистопластика тканеинженерными конструкциями (ТИК), состоящими из полилактидной матрицы, укрепленной фиброином шелка и заселенной гладкомышечными клетками с уротелием, фибробластами и мезенхимальными стволовыми клетками (МСК). Результаты. В 100% случаев замещения участка МП бесклеточной матрицей или скаффолдами, содержащими гладкие миоциты с уротелием и фибробласты, произошло отторжение имплантата с разной степени выраженности воспалительной реакцией и уменьшением емкости МП. Только в группе, получившей ТИК с МСК, напротив, в 5 случаях из 6 произошел лизис матрицы, а емкость МП через 2,5 мес после операции оказалась сравнима с таковой до операции. В месте имплантации определялся участок измененной слизистой оболочки с признаками васкуляризации. Гистологически выявлены начальные стадии репарации и ангиогенеза. При конфокальной микроскопии криосрезов в месте имплантации ТИК определяются меченые клетки, принимающие участие в формировании структуры, сходной с уротелием. Заключение. Показана эффективность использования МСК в составе ТИК для частичного замещения стенки МП. Существует ряд патологических состояний в урологии, которые требуют замещения МП, прежде всего опухолевого и инфекционного характера, при которых аутологичный материал для создания ТИК использовать невозможно. Именно в таких ситуациях и необходима дальнейшая разработка имплантов с использованием аллогенных...

  • Positive experience of transplantation of a multicomponent composite containing allogeneic mesenchymal stem cells after resection of the rabbit bladder wall (description of one experiment).

    by FSBI SPb Research Institute of phthisiopulmonology of the Russian Ministry of Health, N.V. Orlova, A.N. Muravyev, T.I. Vinogradova, N.M. Yudintseva, Fsbi Of Cytology Of Ras, Yu.A. Naschekina, N.V. Zabolotnykh, A.A. Lebedev, M.G. Sheikhov, et al.

    Пациенты с так называемым малым мочевым пузырем (МП) составляют наиболее тяжелый контингент среди больных, страдающих заболеваниями мочеполовой системы, в том числе и туберкулезом [1,2]. Практически в